In the context of MetS, ACE2 deficiency, combined with a significant increase in ACE and AGTR1, would impair the imbalance between the ACE-angiotensin II-AGTR1 (AT1) receptor axis and the ACE2-angiotensin1-7 axis. This evidence concerns the gene ACE2 and metabolic syndrome.